Pharming (PHAR) Convertible Debt (2020 - 2026)
Pharming (PHAR) recorded Convertible Debt of $92.4 million in Q2 2026, up 1.2% from $91.27 million a year earlier but down 1.1% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Convertible Debt (2020 - 2026) Analysis & Trends
At the end of FY2025, Pharming reported Convertible Debt of $92.72 million, up 18.6% from FY2024.
- Annual Convertible Debt has a five-year compound annual growth rate of -9.1% (FY2020 to FY2025).
- Across earlier years, Convertible Debt came in at $78.15 million in FY2024 (-42.8%), $136.6 million in FY2023 (+3.8%), $131.62 million in FY2022 (-5.3%) and $139.01 million in FY2021 (-7.2%).
- Quarterly Convertible Debt has ranged from $120,005 in Q3 2022 to $140.96 million in Q3 2021 over the past five years.
- On a year-over-year basis, Convertible Debt has increased for five consecutive quarters, with an average decline of 5.0% over the last seven quarters.
- Peak year-over-year performance for Convertible Debt in the last five years was growth of 18.6% in Q4 2025, against a decline of 99.9% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $93.39 million (Q1 2026), $92.72 million (Q4 2025) and $93.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Pharming | 738.17 Mn | -91.99 Mn | 141.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.40 Mn |
| Mar 31, 2026 | 93.39 Mn |
| Dec 31, 2025 | 92.72 Mn |
| Sep 30, 2025 | 93.14 Mn |
| Jun 30, 2025 | 91.27 Mn |
| Mar 31, 2025 | 83.85 Mn |
| Dec 31, 2024 | 78.15 Mn |
| Sep 30, 2024 | 92.10 Mn |
| Jun 30, 2024 | 87.32 Mn |
| Dec 31, 2023 | 136.60 Mn |
| Sep 30, 2023 | 129.73 Mn |
| Jun 30, 2023 | 134.18 Mn |
| Mar 31, 2023 | 133.58 Mn |
| Dec 31, 2022 | 131.62 Mn |
| Sep 30, 2022 | 120,005.00 |
| Jun 30, 2022 | 128.24 Mn |
| Mar 31, 2022 | 135.56 Mn |
| Dec 31, 2021 | 140,303.46 |
| Sep 30, 2021 | 140.96 Mn |
| Jun 30, 2021 | 145.44 Mn |
API Access
Pharming Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();